My Speaker List
Amy Ripka

Amy Ripka, PhD

Founder and CEO of Lucy Therapeutics.

“Nobody ever got anywhere by listening to no.”

Amy Ripka is the founder and CEO of Lucy Therapeutics. She is designing a new class of mitochondrial-based therapies for Rett Syndrome and other neurological diseases.

Ripka previously developed drugs to treat infection, cancer, and cardiovascular disease. She is also a member of the scientific advisory boards of Q Biomed Ventures and Caraway Therapeutics.

She received her B.A. in chemistry and music from Northwestern University and Ph.D. in organic chemistry and medicinal chemistry at the University of Wisconsin-Madison. She completed her postdoctoral studies at Scripps Research under Nobel Laureate K. Barry Sharpless.

Featured Videos